P-260: Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX — María‐Victoria Mateos (2022) | RDL Network
P-260: Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX
Nizar J. Bahlis, Philippe Moreau, Hareth Nahi, Torben Plesner, Hartmut Goldschmidt, Kenshi Suzuki, Robert Z. Orlowski, Neil Rabin, Merav Leiba, Albert Oriol, Ajai Chari, Jesús F. San Miguel, Paul G. Richardson, Saad Z. Usmani, Lisa O’Rourke, Kaida Wu, Tineke Casneuf, Christopher Chiu, Xiang Qin, Meletios A Dimopoulos
Nizar J. Bahlis, Philippe Moreau, Hareth Nahi, Torben Plesner, Hartmut Goldschmidt, Kenshi Suzuki, Robert Z. Orlowski, Neil Rabin, Merav Leiba, Albert Oriol, Ajai Chari, Jesús F. San Miguel, Paul G. Richardson, Sharjeel Usmani, Lisa O’Rourke, Kang Wu, Tineke Casneuf, Christopher Chiu, Xiang Qin, Meletios A Dimopoulos
Jonathan L. Kaufman, Meletios A Dimopoulos, Merav Leiba, James Morton, P. Joy Ho, Kihyun Kım, Philippe Moreau, Heather J. Sutherland, Shinsuke Iida, Jin Seok Kim, H. Miles Prince, Albert Oriol Rocafiguera, Nizar J. Bahlis, Ajai Chari, Hervé Avet‐Loiseau, Christopher Chiu, David Soong, Jon Ukropec, Ming Qi, Jesús F. San Miguel
Meletios A Dimopoulos, J. San‐Miguel, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, James Morton, P. Joy Ho, K. Kim, Naoki Takezako, Philippe Moreau, H.J. Sutherland, Hila Magen, Shinsuke Iida, Jin Sung Kim, H. Miles Prince, Tara Cochrane, Albert Oriol, Nizar J. Bahlis, Ajai Chari, Lisa O’Rourke,
Meletios A Dimopoulos, Darrell White, Lofti Benboubker, Gordon Cook, Merav Leiba, James Morton, P. Joy Ho, Kihyun Kım, Naoki Takezako, Sonali Trivedi, Kaida Wu, Tineke Casneuf, Christopher Chiu, Jordan M. Schecter, Philippe Moreau
Discussion(0)
No comments yet. Be the first to comment.